{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T16:07:53Z","timestamp":1775923673440,"version":"3.50.1"},"reference-count":5,"publisher":"PAGEPress Publications","license":[{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Reports"],"abstract":"<jats:p>Perifolliculitis capitis abscedens et suffodiens (PCAS) and acne conglobate (AC) are often treated with isotretinoin and tumor necrosis factor alpha (TNF-\u03b1) inhibitors in Europe and the United States. Treatment with these drugs is uncommon in Asia, and alternative treatment options are limited. In this paper, we report the case of a Japanese patient who presented with PCAS and AC and was treated successfully with adalimumab.<\/jats:p>","DOI":"10.4081\/dr.2023.9699","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T08:39:42Z","timestamp":1685954382000},"source":"Crossref","is-referenced-by-count":1,"title":["A case of perifolliculitis capitis abscedens et suffodiens and acne conglobata treated effectively with a TNF-\u03b1 inhibitor"],"prefix":"10.4081","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3709-5675","authenticated-orcid":false,"given":"Shinpei","family":"Miura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroo","family":"Amano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2549","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"key":"10956","doi-asserted-by":"crossref","unstructured":"Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa. J Eur Acad Dermatol Venereol. 2015; 29:619-44.","DOI":"10.1111\/jdv.12966"},{"key":"10957","doi-asserted-by":"crossref","unstructured":"Wu KK, Dao H Jr. Off-label dermatologic uses of IL-17 inhibitors. J Dermatol Treat .2020; 9:1-7.","DOI":"10.1080\/09546634.2020.1737638"},{"key":"10958","doi-asserted-by":"crossref","unstructured":"Melnik BC, John SM, Chen W, Plewig G. T helper 17 cell\/regulatory T-cell imbalance in hidradenitis suppurativa\/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities. Br J Dermatol. 2018; 179:260-72.","DOI":"10.1111\/bjd.16561"},{"key":"10959","doi-asserted-by":"crossref","unstructured":"Mansouri Y, Martin-Clavijo A, Newsome P, Kaur MR. Dissecting cellulitis of the scalp treated with tumour necrosis factor-\u03b1 inhibitors: experience with two agents. Br J Dermatol. 2016; 174:916-8.","DOI":"10.1111\/bjd.14269"},{"key":"10960","doi-asserted-by":"crossref","unstructured":"Kamil MAA, Chandran NS, Sulistyaningrum SK, Rajagopalan M, et al. The Asia Pacific Hidradenitis Suppurativa (APHiS) foundation: promoting hidradenitis suppurativa research in the Asia Pacific. Int J Dermatol. 2020; 59:e289\u201390.","DOI":"10.1111\/ijd.14960"}],"container-title":["Dermatology Reports"],"original-title":[],"link":[{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/dr\/article\/download\/9699\/9102","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/dr\/article\/download\/9699\/9102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T08:39:46Z","timestamp":1685954386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/dr\/article\/view\/9699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":5,"URL":"https:\/\/doi.org\/10.4081\/dr.2023.9699","relation":{},"ISSN":["2036-7406","2036-7392"],"issn-type":[{"value":"2036-7406","type":"electronic"},{"value":"2036-7392","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,5]]}}}